wrote 2 weeks ago: Total return is always the name of the game when it comes to investing success. Stocks that pay divi … more →
wrote 2 weeks ago: The world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are … more →
wrote 1 month ago: Investors love dividends, and this component of investing plays a very important part of the total r … more →
wrote 1 month ago: When the holidays wound down and we started off 2013, all the Wall St. firms started to put out thei … more →
wrote 2 months ago: … more →
wrote 2 months ago: The U.S. Food and Drug Administration (FDA) last night rejected an application from Johnson & Jo … more →
wrote 3 months ago: Â Â Courtesy of “The ETF Professor”–his work appears courtesy of Benzinga.com, and … more →
wrote 3 months ago: S&P 500 dividend growth continues to outpace earnings growth, a trend that likely will continue … more →
wrote 3 months ago: PMI data from Asia shows the slowing of economies there. (Reuters) A private equity buyout of Dell I … more →
wrote 4 months ago: I haven’t seen my good ol’ friend for a long time (at least it felt like it) And we alwa … more →
wrote 5 months ago: Drug developer Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) watched its shares plummet 35% yesterday fo … more →
wrote 5 months ago: So last week the first part of ASK A MODEL: Singapore/Malaysia was released and it gave a long winde … more →
wrote 5 months ago: model Ming Xi via heavyeyes … more →
wrote 6 months ago: … more →
wrote 6 months ago: … more →
wrote 7 months ago: The Non-Financial Cost of Stagnation: “Social Recession” and Japan’s “Lost G … more →
wrote 7 months ago: … more →
wrote 7 months ago: … more →